Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362.
about
Repeated cocaine treatment enhances HIV-1 Tat-induced cortical excitability via over-activation of L-type calcium channels.Patterns of substance use among HIV-positive adults over 50: implications for treatment and medication adherenceHIV prevention in care and treatment settings: baseline risk behaviors among HIV patients in Kenya, Namibia, and Tanzania.Pain is associated with risky drinking over time among HIV-infected persons in St. Petersburg, Russia.Stimulant use patterns and HIV transmission risk among HIV-serodiscordant male couples.Barriers to antiretroviral therapy adherence and plasma HIV RNA suppression among AIDS clinical trials group study participantsThe unique challenges facing HIV-positive patients who smoke cigarettes: HIV viremia, ART adherence, engagement in HIV care, and concurrent substance useRelative Efficiency of Field and Online Strategies in the Recruitment of HIV-Positive Men Who Have Sex With Men.Efficacy, adherence and tolerability of once daily tenofovir DF-containing antiretroviral therapy in former injecting drug users with HIV-1 receiving opiate treatment: results of a 48-week open-label studyOperationalizing treatment as prevention in Los Angeles County: antiretroviral therapy use and factors associated with unsuppressed viral load in the Ryan White system of careIntentional Medication Nonadherence Because of Interactive Toxicity Beliefs Among HIV-Positive Active Drug Users.Substance use predictors of poor medication adherence: the role of substance use coping among HIV-infected patients in opioid dependence treatmentBinge drinking is associated with differences in weekday and weekend adherence in HIV-infected individuals.HIV-infected adolescents in southern Africa can achieve good treatment outcomes: results from a retrospective cohort studySubstance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances.Categorization of psychoactive substances into "hard drugs" and "soft drugs": a critical review of terminology used in current scientific literature.90-90-90-Plus: Maintaining Adherence to Antiretroviral Therapies.Challenges to HIV management among youth engaged in HIV care.Direct and Indirect Effects of Heavy Alcohol Use on Clinical Outcomes in a Longitudinal Study of HIV Patients on ART.The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United States.Psychiatric Diagnoses among an HIV-Infected Outpatient Clinic Population.Alcohol-antiretroviral interactive toxicity beliefs as a potential barrier to HIV pre-exposure prophylaxis among men who have sex with menAssessing Problematic Substance Use in HIV Care: Which Questions Elicit Accurate Patient Disclosures?Substance Use and Adherence Among People Living with HIV/AIDS Receiving cART in Latin America.Highly specific reasons for nonadherence to antiretroviral therapy: results from the German adherence study.Gender differences in quality of life outcomes of HIV/AIDS treatment in the latent feminization of HIV epidemics in Vietnam.Prevalence and Associations of Illicit Drug and Polydrug Use in People Living with HIV in Vienna.
P2860
Q33605370-83F32406-F1F6-4567-A997-7D68D7BE6419Q33637963-E81C4710-DC31-44F1-BF73-9DED67A77F9EQ34607847-CFF518FB-04F0-42CE-888D-15F06C38E75BQ34614139-CE3D3DCC-657A-48FD-A5E9-0EA302FD5BDCQ34977373-EFF3BE15-426B-4AB3-80E9-2AD933A1FCA0Q35156644-C785807F-1B8D-400E-9B86-AA318186206BQ35556761-8EE6DB7F-6ED3-4FD5-8373-81C20912064AQ35889811-F1AABEB7-C616-46B1-BCAE-104CD6DD5DF0Q36105831-CD56D700-C62D-4FFC-834F-7747468F70D1Q36124284-B1247A80-109B-495B-B627-65B34408626DQ36289131-BBAC6825-6E4C-407A-B956-6DA895D611D1Q36784049-DBA266FB-F6DC-44B9-9FCB-E6F78EE45E71Q36882901-80705C82-AEA8-4B66-B066-504AC2EFA520Q37020308-4D491C09-C4ED-4E2F-9D4E-AD3621A69C82Q37149288-EDDF3445-DAEB-49E6-9B73-FC365C932D4AQ38708946-D30EB8AC-AD7A-4525-B45C-12163C2CBA72Q38780710-AC59A254-08C5-4643-BEEF-2400D890B9A9Q39616582-721920F5-7863-4A6B-99BA-421DD23A4E24Q39620568-85229190-08AD-4868-B975-D6A37601272AQ40179664-43362D98-9492-46D9-8F16-AA70B83B5B71Q40231209-0FA3ED6B-DDA5-4D1F-9B4B-884673051FD5Q41570992-8D470632-6406-48B3-9438-DBC7ABCA5AB9Q41648066-A89AD903-423A-45FD-9E9E-740CB18AEE39Q42707236-D1ECFB26-99A2-44B6-9804-FB32D2C8D055Q47136520-440A94EA-B82F-4A92-8E0B-3B0F2E58E18CQ48475495-DD16529B-7C03-4E21-814A-129DA5AD06ACQ54974866-85250D8B-A86B-42D7-B14F-9742F69387BD
P2860
Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Association of ongoing drug an ...... death: results from ACTG 362.
@ast
Association of ongoing drug an ...... death: results from ACTG 362.
@en
Association of ongoing drug an ...... death: results from ACTG 362.
@nl
type
label
Association of ongoing drug an ...... death: results from ACTG 362.
@ast
Association of ongoing drug an ...... death: results from ACTG 362.
@en
Association of ongoing drug an ...... death: results from ACTG 362.
@nl
prefLabel
Association of ongoing drug an ...... death: results from ACTG 362.
@ast
Association of ongoing drug an ...... death: results from ACTG 362.
@en
Association of ongoing drug an ...... death: results from ACTG 362.
@nl
P2093
P2860
P921
P1433
P1476
Association of ongoing drug an ...... death: results from ACTG 362.
@en
P2093
Annabelle M de St Maurice
Hongyu Jiang
J Allen McCutchan
Judith S Currier
Kevin R Robertson
Paige L Williams
Susan E Cohn
Susan L Koletar
P2860
P304
P356
10.1080/09540121.2010.525617
P577
2011-06-01T00:00:00Z